Navigation Links
Microbes, Inc. Extends Warrant Tender Offer
Date:8/7/2008

NEW YORK, Aug. 7 /PRNewswire/ -- Microbes, Inc. today announced that it has extended its current offer to purchase any and all of its outstanding Class B Common Stock Purchase Warrants, Class 1 and Class B Common Stock Purchase Warrants, Class 2 until 12:00 midnight, New York City time, on Friday, August 15, 2008. The offer was scheduled to expire at 12:00 midnight, New York City time, on August 7, 2008.

The extension will provide Warrant holders additional time to determine whether to tender their Warrants in response to the Company's tender offer. Microbes is offering holders of the Warrants $0.25 per share in cash, without interest, for each share of Class B Common Stock, $.001 par value, for which a Warrant may be exercised and for which the Warrant remains unexercised at the time of acceptance in the tender offer.

The tender offer is being made solely by the Offer to Purchase and the related Letter of Transmittal. Holders of Warrants are urged to read the Offer to Purchase and the related Letter of Transmittal, as well as any amendments or supplements thereto when they become available, because they contain important information.

Microbes' business involves the manufacture and sale of microbial products to increase the yield of oilfields and food crops. Microbes is headquartered in The Woodlands, Texas.


'/>"/>
SOURCE Microbes, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Congress Extends 2007 Reimbursement Rates for Radioimmunotherapies for 18 Months
2. Unilever Extends Their GeneGo MetaCore License
3. Rentschler Biotechnologie Extends Capacities for Mammalian Cell Culture Manufacturing
4. Symmetry Medical Extends 10-K Filing Beyond April 14, 2008 Target
5. Gerson Lehrman Group Extends Partnership With BIO to Provide Scientific Expertise for the First Annual BIO National Venture Conference
6. Ingenuity Systems Extends Enterprise-Level Software Agreement With GlaxoSmithKline
7. Actavis Receives Approval for Irinotecan Hydrochloride Injection; Extends US Portfolio with First Injectable Product
8. Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million
9. Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions
10. GSK Extends GeneGo License and Adds New Products
11. Roche Extends Tender Offer for Ventana
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... JOHNSTON, Iowa (PRWEB) , ... October 12, 2017 ... ... company based in Vilnius, Lithuania, announced today that they have entered into a ... collaboration is to provide CRISPR researchers with additional tools for gene editing across ...
(Date:10/12/2017)... , ... October 12, 2017 ... ... has launched Rosalind™, the first-ever genomics analysis platform specifically designed for life ... Named in honor of pioneering researcher Rosalind Franklin, who made a major ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back ... 8th June 2018 in San Francisco, CA. The Summit brings together current and former ... CEOs, board directors and government officials from around the world to address key issues ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are the main ... people each year. Especially those living in larger cities are affected by air pollution ... of the most pollution-affected countries globally - decided to take action. , “I knew ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by Solution ... Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to 2022", ... 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
Breaking Biology News(10 mins):